Invest in

Biotech Breakthroughs

3.1%
0.3%
1.7%

Feeling Better About Biotech

The next big cure for a complex, scary disease is unlikely to come from old-school pharma. It’s likely coming from biotech. Scientists, investors, and patients are all banking on the $93 billion biotech industry.[1] It’s outpaced Big Pharma in finding treatments for cancer, AIDS, multiple sclerosis, and other diseases. The FDA approved 43 drugs in 2012, a 20% jump from the previous year.[4] Big Pharma has responded by snapping up promising biotech and smaller pharmaceutical companies, at lofty valuations, with premiums for several public companies in excess of 50%.[2] In fact, 2013 was a big year for the biotech industry, with $29B in M&A deals through the 1st half of 2013.[3] This motif includes only biotech companies with at least two years of cash flow to help screen out companies at greater risk of losing money. See More
3.1%
0.3%
1.7%
Invest in Thematic Portfolios
Create your own customizable basket of up to 30 stocks or ETFs for as low as $9.95.
Join over 100,000 Motif customers customizing, building, and sharing motifs.
Portfolio Index 1 YR Return
Open a Motif account to view and trade this thematic portfolio
Weight Segment & Stocks Symbol 1 YR Return
56.7% Research & Diagnostics 20.1%
15.5% Danaher Corporation DHR 40.5%
14.0% Thermo Fisher Scientific Inc. TMO 20.0%
5.7% 8xxxx 8xxxxxxx 8xxx 8xx 88.8%
4.4% 8xxxxxx 8xxxxxxxxxxx 8xx 8 88.8%
4.2% 8xxxx 8xxxxxxxxxx 8xxxxxxxxxxx 8xx 88.8%
3.7% 8xxxxxx 8xxxxxxxxxxx 8xxx 8xx 8xx 88.8%
3.1% 8xxxxx 8xxxxxxxxxx 8xx 88.8%
2.9% 8xxxxx 8xxx 8xxx 88.8%
2.4% 8xxxxxxxxxxxxx 8xxxxxxxxxxxx 8xxx 8xx 88.8%
0.9% 8xxxxxxxxxx 8xxx 8xx 88.8%
21.2% Other Biotech 2.0%
15.8% Amgen Inc. AMGN 7.0%
3.5% 8xxxxxxxx 8xxxxxxxxxxxxxx 8xxx 8xxx 88.8%
1.2% 8xxxxx 8xxxxxxxxxxx 8x 8xxx 88.8%
0.7% 8xx 8xxxxxxxx 8xxx 8xxx 88.8%
14.4% Mature Biotechnology 19.9%
9.5% 8xxxxx 8xxxxxxx 8xxx 8xxx 88.8%
4.9% 8xxxxx 8xxx 8xxx 88.8%
3.1% Commercial Growth Biotech 5.5%
3.1% 8xxxxxx 8xxxxxxxxxxxxxx 8xxx 8xxx 88.8%
2.7% Development Stage Biotech 37.0%
1.7% 8xxxxxxxx 8x 8xxxx 8xx 8xxx 88.8%
0.9% 8xxxxxxxxx 8xxxxxxxx 8xxx 8xxx 88.8%
2.0% Early Commercial Biotech 23.7%
2.0% 8xxxxxxx 8xxxxxxxxxxxxx 8xxx 8xxx 88.8%
Quotes delayed 15 mins. Currently Aug 18, 2019 12:32:17 AM. Fields are marked with -- when data is unavailable.